PCR | GenomeWeb

PCR

The firm's reagents and disposables business was the biggest gainer, with a 12 percent revenue increase in the quarter. 

The firm saw decreases in its core diagnostics business that were offset in part by revenues from newly-acquired Magellan Diagnostics.

The test, which will be based on AmoyDx's proprietary real-time PCR technology, will identify cancer-associated mutations in the RAS gene family.

Sales of the firm's infectious disease and women's health products were credited with driving the year-over-year increase in revenues.

The firm launched the multiplex PCR-based test this week on its Spartan Cube platform to support patient enrollment in Alzheimer's clinical trials.

Method and kit for detection of microorganism
Polynucleotide amplification
Bioagent detection systems, devices, and methods
Systems, methods, and devices for assessing microbiota of skin
Visualization tool for qPCR genotyping data
Biochip and target DNA quantitative method